Gastrointestinal Pharmacology
Springer, Cham
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Chapter title |
Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches
|
|---|---|
| Chapter number | 122 |
| Book title |
Gastrointestinal Pharmacology
|
| Published in |
Handbook of experimental pharmacology, February 2017
|
| DOI | 10.1007/164_2016_122 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-956359-6, 978-3-31-956360-2
|
| Authors |
Bincy P. Abraham, Tasneem Ahmed, Tauseef Ali, Abraham, Bincy P., Ahmed, Tasneem, Ali, Tauseef |
| Abstract |
Inflammatory bowel diseases, most commonly categorized as Crohn's disease and ulcerative colitis, are immune mediated chronic inflammatory disorders of the gastrointestinal tract. The etiopathogenesis is multifactorial with different environmental, genetic, immune mediated, and gut microbial factors playing important role. The current goals of therapy are to improve clinical symptoms, control inflammation, prevent complications, and improve quality of life. Different therapeutic agents, with their indications, mechanisms of action, and side effects are discussed in this chapter. Anti-integrin therapy, a newer therapeutic class, with its potential beneficial role in both Crohn's disease and ulcerative colitis is also mentioned. In the end, therapeutic algorithms for both diseases are reviewed. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 193 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 31 | 16% |
| Student > Master | 14 | 7% |
| Student > Doctoral Student | 13 | 7% |
| Other | 12 | 6% |
| Researcher | 12 | 6% |
| Other | 24 | 12% |
| Unknown | 87 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 22% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 9% |
| Biochemistry, Genetics and Molecular Biology | 10 | 5% |
| Immunology and Microbiology | 7 | 4% |
| Nursing and Health Professions | 6 | 3% |
| Other | 18 | 9% |
| Unknown | 92 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2020.
All research outputs
#15,240,835
of 22,660,862 outputs
Outputs from Handbook of experimental pharmacology
#392
of 643 outputs
Outputs of similar age
#197,167
of 310,815 outputs
Outputs of similar age from Handbook of experimental pharmacology
#8
of 9 outputs
Altmetric has tracked 22,660,862 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 643 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,815 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.